Skip to main content
KREF $5.21 -0.76%
KREF logo
KREF · KKR Real Estate Finance Trust Inc.
Track KREF — free
$5.21 -0.04 (-0.76%) At close · Nov 3
Market Cap
$300.86M
Shares
57.31M
Volume · Nov 3 1.14M Avg daily vol (3M) 882.1K
All webcasts

Earnings call · FY2026 Q3

KKR Real Estate Finance Trust Inc. (KREF) Q3 2026 Earnings Call Transcript

Concluded Oct 29, 2026 Audio replay
Oct 29, 2026 34:49 44 turns
Period
FY2026 Q3
Runtime
34:49
Sources
5 artifacts
Diluted EPS -$0.11 -191.7% YoY
Net income -$919,000 -106.7% YoY
Open full screen Slides 28 8-K 10-Q

Transcript & audio

34:49 Audio
Operator

To the KKR Real Estate Finance Trust Inc. 3rd Quarter 2026 Financial Results Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on your telephone keypad. To withdraw your question, please press star, then 1 again. Please note this event is being recorded. I would now like to turn the conference over to Jack Swatala. Please go ahead.

Jack Switala Head of Investor Relations

Great. Thanks, Operator, and welcome to the KKR Real Estate Finance Trust earnings call for the third quarter of 2026. As the Operator mentioned, this is Jack Swatala. This morning, I'm joined on the call by our CEO, Matt Salem, our President and COO, Patrick Masson, and our CFO, Kendra Decius. I'd like to remind everyone that we will refer to certain non-GAAP financial measures on the call, which are reconciled to GAAP figures in our earnings release and in the supplementary presentation, both of which are available on the Investor Relations portion of our website. This call will also contain certain forward-looking statements, which do not guarantee future events or performance. Please refer to our most recently filed 10-Q for cautionary factors related to these statements. Before I turn the call over to Matt, I will go through our results. For the third quarter of 2026, we reported gap net loss of $6 million, or negative $0.11 per share. Book value as of September 30th was $10.14 per share. We reported a distributable loss of $152 million, or negative $2.64 per share. Share. Distributable earnings before realized losses and strategic review expenses were $5 million, or $0.09 per share. Lastly, we paid a $0.10 cash dividend with respect to the third quarter. With that, I'd now like to turn the call over to Matt.

Thanks, Jack. Good morning, everyone, and thank you for joining us today. Let me begin with a brief update on the strategic review process. As we announced in July, KRUF's board established a strategic review committee composed solely of independent directors to evaluate potential strategic alternatives. Since that announcement, the committee has retained a financial advisor and legal counsel and continues to evaluate the company's strategic alternatives. Given the review is ongoing, we will not be providing any further commentary on the process during today's call. Turning to the broader commercial real estate market, the recent increase in interest rates has created renewed pressure on property values, presenting both opportunities and challenges for real estate lenders. Existing borrowers will be impacted by higher debt service costs and lower refinancing proceeds, particularly for assets financed at peak valuations in 2021 and early 2022. We expect this environment to extend resolution timelines and in some cases result in additional credit losses. At the same time, these dynamics should drive increased demand for refinancing and recapitalization capital as borrowers work through upcoming maturities. Importantly, underlying property fundamentals remain generally constructive across most sectors, supported by tenant demand and a meaningful slowdown in new construction activity. As we continue to reposition KRAS portfolio, we believe this environment provides an attractive opportunity to redeploy capital into new loans with compelling credit characteristics and risk-adjusted returns. Portfolio repayment activity has been particularly strong, with $2.4 billion of repayments year-to-date, surpassing our $2 billion expectation for the year. This quarter, repayments totaled $1.2 billion. This quarter's repayments nearly matched our annual repayments for each of 2024 and 2025. 5. Importantly, much of this activity has been concentrated in our older vintage loans, accelerating the natural rotation of the portfolio, and reducing our exposure to loans originated during the 2021 and 2022 market environment. Those vintages accounted for over 80% of the repayments this year. We continue to make substantial progress executing the portfolio action plan we outlined at the beginning of the year. Our priorities have been to accelerate the resolution of watchlist and legacy office exposure, address our life science portfolio, and reposition the portfolio toward newer vintage loans with more attractive credit characteristics. During the quarter, we resolved three additional watchlist loans. While the pace of resolution has been encouraging, the timing and ultimate valuations of remaining assets is challenging. We continue to actively pursue monetization strategies for these assets, although some transactions previously anticipated to close before year-end are now likely to extend into the first half of 2027. We remain focused on advancing these resolutions while maintaining a disciplined approach to maximizing recovery. Given the more challenging liquidity and valuation environment, we could see an increase in reserves in the near term as resolution processes advance and market conditions continue to evolve. With that, I'll turn the call over to Patrick.

Thanks, Matt. Good morning, everyone.

I'll begin with origination activity. During the quarter, we originated $157 million of loans, including a Class A senior housing portfolio secured by four properties across the U.S., and a Class A Texas office property. From a broader market perspective, conditions for new investments remain constructive. Credit spreads have been relatively stable, financing for loans remains readily available, and liquidity across markets remains healthy. We expect our pace of originations to remain measured. Given our focus on maintaining balance sheet flexibility, we have been deliberate in deploying capital, rather than seeking to replace repayments with new loans on a dollar-for-dollar basis. Turning next to balance sheet and liquidity, the combination of significant repayment activity and our disappointed approach to capital management has meaningfully strengthened KREF's financial position throughout the year. At quarter end, liquidity increased to approximately $853 million, including $166 million of cash, $53 million of loan principal repayments held by a servicer following a repayment on the last day of the quarter, and $600 million of undrawn capacity on our corporate revolver. This represents one of the highest liquidity positions for KREF's history, well above the historical average of approximately $600 million. Importantly, this liquidity provides us with significant flexibility as we continue to execute our portfolio strategy. We also continue to further optimize our financing structure. During the quarter, we exercised optional redemptions on our two remaining CRE CLOs, completing the retirement of both transactions. Given the substantial repayment activity and reduction in the underlying collateral pools, these transactions have become less efficient financing structures relative to other non-market-to-market financing alternatives available to CAREF. Strong repayment activity during the quarter also drove a meaningful reduction in leverage, with our debt-to-equity ratio declining from 2.6 times to 2.2 times, and total leverage declining from 4.3 times to 3.1 times, below our historical target range, and we expect leverage to remain below the historical range for the fourth quarter. In summary, the third quarter represented another important step in executing the priorities established at the beginning of the year. We materially reduced the watch list, advanced the resolution of legacy exposures, exceeded our full-year repayment expectations ahead of schedule, and further strengthened our liquidity position.

With that, we're happy Thank you.

Operator

We will now begin the question and answer session. To ask a question, you may press star, then one on your touchtone phone. If you're using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question, please press star, then one again. At this time, we will pause momentarily to assemble our roster. Your first question comes from Tom Catherwood with BTIG. Your line is open.

Tom Catherwood Analyst — BTIG

Excellent. Thank you, and good morning, everybody. Matt, I want to go back to something you said in your prayer remarks about that you could see or we could see more reserves in the near term as the resolution process advances. So the question that pops in my head is kind of what's holding you back from getting ahead of that and taking worst-case scenario type marks right now? Is it that you don't have the market comps because transactions are slow, or is it something else that's holding you up from kind of getting ahead of that and kind of creating a worst-case baseline?

Yeah, Tom, thanks for the question. Number one, markets can change. And number two, just given how the liquidity in some of these markets, we don't know exactly where these processes can end up. So as we kind of continue to work through those, we'll obviously adjust it in real time for what we're seeing. But just understanding kind of where the overall market is today, we wanted to obviously highlight that as we continue to work through the resolutions here.

Tom Catherwood Analyst — BTIG

And you mentioned resolutions on the watch list. I assume that this applies to kind of the remaining legacy loans. Obviously, that amount came down in 3Q with repayments, but are you expecting more modifications? Are you expecting more things that you think could have reserves or more migrations out of that legacy but three-rated or better portfolio?

I think everybody, including ourselves, is looking at their portfolios, you know, in a new light now, clearly with adjusted values and the interest rate that, you know, we're living in today, and, you know, I think where we're seeing, you know, potential noise, I would say, is certainly on some of the multifamily. That feels like it's been the most impacted in kind of the rate hike environment, in those vintages we called out on the call in terms of the 2021 and 2022 vintages. So that's probably the area we're watching closely. We've got a lot of repayments, and a lot of those loans, like we said, this was a huge repayment quarter for us, equaling almost all of last year and the year before. And 80% of that, as we highlighted, was in those vintages. So we are seeing real velocity there, but values are down a little bit, and some of those loans are closer to the sun, and so we'll have to continue to kind of monitor those as they come up for refinance.

Tom Catherwood Analyst — BTIG

Quick follow-up on that one, Matt. Do you have a sense of, for those legacy multifamily loans you mentioned, do you have a sense of where those debt yields sit right now?

I mean, obviously, there's a huge range. I think on average, we're well into the sixes, but it's the stuff at the lower end of that range that is going to be the most acute and have the most problematic or the most problems, obviously, refinancing. So those are the ones we're really focused on. But we'll kind of continue to see how the market evolves from a value perspective. I think it's changing, I'd say, on a day-to-day basis as the market kind of resets expectations around not only cap rates, but just growth profile as well.

Tom Catherwood Analyst — BTIG

Got it. Appreciate the answers. Thanks, Matt.

Operator

Your next question comes from Jade Ramani with KBW. Your line is open.

Jade Ramani Analyst — KBW

Thank you very much. Can you give any color on the Boston life science resolution? I didn't see clearly in the 10Q what happened to that loan. So was that sold or acquired? Any color would be helpful.

Thanks, Patrick. Happy to take that. So on that loan, we had financing on that. That was non-recourse financing. And so as values have changed on that asset, we assigned that loan back to the lender. And so what you see reflected in this quarter was the loss on our portion of that loan, and it's obviously removed from the portfolio at this point.

Jade Ramani Analyst — KBW

Okay, that's helpful. Thank you. On the multifamily portfolio, can you comment as to what percentage is pre-2023 vintage and what the in-place debt yields are on that? And also, can you further comment if there's a property that has, say, a 5.5% to 6% debt yield? Would that require KREF to absorb a loss? Because that would imply close to 100% LTV, so not necessarily a loss, but it depends on the friction points and what happens in such a situation.

Yeah, I don't have the exact percentage of the 2021 and 2022 multifamily in front of me, so we can kind of follow up on that. On the second part of your question, the 5.5% to 6% debt yield area, I think certainly we'd be watching those very closely. It really comes down to two things. It's number one, what's the embedded growth in the market? Because the five and a half in New York City or San Francisco or some of these markets that are experiencing real growth is very different than some of the Sunbelt markets that are still absorbing supply, as you well know. So there's going to be a range of cap rates depending on the market. And the second thing is really around sponsor. And number one, what's their liquidity level? What else is in their portfolio that they're dealing with? And what's their willingness to continue to play forward and try to continue to grow cash flows over time to enhance their outcomes on their equity? So, these are all in play, and we've seen it across the board. I certainly think, having a portfolio outside of KREF as well, that we're seeing, you know, marginally more capitulation in the multifamily sector from borrowers just given this latest rate hike. So that speaks a little bit to the second point I'm making that I think you are seeing a little bit more velocity, whereas before we were getting a lot more paydowns and playing it forward. I think there's been slightly more capitulation in the market today around some of that. But those are certainly the ones that were – that corridor is certainly the ones that we're focused on in terms of their ability to refinance.

Jade Ramani Analyst — KBW

A follow-up would be with multifamily as a more liquid asset class and fundamentals potentially nearing a trough, could you devise an alternative strategy to fund REO with leverage and hold some of these assets, more so than you've done with, say, office? Does that make any sense, or do you think the better outcome is to just work these out, share in some of the value reduction and take hits to book value?

Well, I think similar to every

time we have an issue in the portfolio, we're going to look at all the options available to us and how do we optimize the outcome and maximize recovery for the balance sheet. And you think about what we did in Raleigh, North Carolina on that multifamily deal. We felt like we could go in and stabilize cash flow and operations there and then sell it into a better environment. And I think we're proving that out on the operations side for sure. And we feel very good about, you know, how the occupancy there and where we are on the cash flow basis. And obviously, they carry a lot easier, to your point, I think, is what you might be suggesting. And, you know, then some of the life science we have, for instance, where, you know, you sort of have the tenants there, and so there's a kind of a net cost on an ongoing basis. So that certainly will factor into the analysis. Hard to predict the Obviously, the market's very dynamic right now, but when I look at our portfolio, I don't see a wave of opportunities to do that if that's part of the question. I think we could have isolated situations where the loan is closed and we ultimately have to take some reserves on it, but I don't think we're looking at it like, wow, this is going to be a big portfolio of multi that we have to make decisions on. So, that may help you think through it a little bit.

Jade Ramani Analyst — KBW

Thank you.

Operator

Your next question comes from Rick Shane with J.P. Morgan. Your line is open.

Rick Shane Analyst — J.P. Morgan

Hey, guys. Thanks for taking my question this morning. Look, you guys, I know you won't comment per se on the strategic review process, but at the same time, you have two other things going on. One is resolution of the existing portfolio. And then the real question is, how are you sort of approaching the market in terms of additional investment? You guys did originate loans this quarter, but leverage is now below target ratio. You're sitting on a lot of liquidity. Do you see yourselves as active participants in the market? And more importantly, from sort of a management perspective, how do you sort of motivate employees in the context of this sort of potential uncertainty? Right.

Thank you for the question. I guess just to be direct, 100% we're active participants in the market. We originated two loans this quarter. I'll come back to that piece of the question here in a second. Let me answer your final piece of the question. Keep in mind that the team that invests on behalf of KRAF invests for other pools of capital within KKR as well. So this is a smaller piece of our overall business, and that business is continuing to grow, and we have lots of different types of capital that we invest there. We invest bank capital. We invest insurance capital. We invest debt fund capital. So there's lots of capital, and we're actively originating loans across our $43 billion of AUM within real estate credit at KKR. So there's lots going on. And the motivation question you had, I don't think is particularly relevant for our team and our situation. And then when we just think about how we're positioned in the market, I think you're right to kind of put a few things in there. When I look at this quarter in particular, let's just understand last quarter we were above our target leverage ratio, and we had talked about, okay, wanting to bring that down. So we were able to accomplish that. The second thing, which I highlighted earlier, was we got a ton of repayments this quarter. And you never quite know, especially in a market where the Fed is hiking again, like, okay, what's going to come through? What's not? Do things get extended? And some of those were actually pretty back-ended in the quarter. So you had this moment in time where certainly that contributed to it, where there's a lot coming through in the quarter, a lot coming through towards the end. And we weren't leaning in to originations either because we were trying to bring down leverage and trying to understand kind of where we did in the corner. So some of it is just the complexity around that. And I'd say the last piece of it is, you know, creating some more flexibility right now and optionality for ourselves, I don't think is a bad thing either, where we start to look at what's going on in the market, values are resetting, you know, perhaps the loan you're going to make tomorrow is, you know, better than the loan you could have made 60 days ago. So, you know, I think there's also reason to just be prudent as we kind of think about what's going on in the market today. So none of those factors are the single determinant of, like, you know, where we snap the line at the end of September, but they're all kind of factoring into it, you know, of how we kind of think about, you know, to go forward here. But certainly, you know, closed loans in the quarter and are active.

Rick Shane Analyst — J.P. Morgan

No, look, it's a very fair point, and you linked up something that I didn't, that I heard, but didn't link up, which is how heavy the repayments were at the very end of the quarter. And given the uncertainty that the third quarter events created, the macro events created, and the potential sort of extension of timelines on anything in the meeting of the minds, makes sense to sort of be careful until all of that stuff closes. I don't know if you covered this. I apologize, but it looks like the cadence of the buyback really was just in July and then slowed down. Is that related to the strategic review, or how should we think about that going forward, particularly given the leverage, et cetera?

Yeah, I think you're right to call that out. And I think we mentioned this on the last call. The buybacks, think about that. Strategic review is one of the key things they're looking at, of course, is capital allocation. And so share buybacks will be part of that, and that really effectively impacted, if you will, our participation in that investing piece of the business after that announcement.

Rick Shane Analyst — J.P. Morgan

Okay, actually, when I really think about that from a legal perspective, it totally makes sense. Thank you for pointing it out and answering that question kindly, but totally, at the end of the day, it doesn't really make sense to be buying back stock when you're doing that, because you've got information. Anyway, I get it. Thank you guys for taking my questions, as always.

Thank you. Appreciate you joining.

Operator

Again, if you have a question, please press star, then one. Your next question comes from Chris Mueller with Citizens. Your line is open.

Chris Mueller Analyst — Citizens

Hey, guys. Thanks for taking the questions. So, looking at your slide deck, the interest sensitivity slide stands out. Can you just talk through why higher rates are not a more meaningful benefit to the bottom line?

Chris, good morning. It's Patrick. I'll take that. Yes, it's a good sort of highlight. We would expect normally, right, that you would get some benefit from higher rates. A couple of factors here. One, we're at the point where we've got some floors that are effectively pretty close. So as we think about going up a little bit higher, it's not changing that much. We're not getting the additional benefit on the asset side. The other factor is just that if you look at our debt outstanding that's subject to a floating rate and look at our loan assets outstanding that are subject to a floating rate, they're fairly close to each other. We're not obviously levered one-to-one. We've got a lot of value tied up, for example, in the REO assets, but the REO assets aren't producing income, right? So they're not subject to the benefit of higher interest rates. So it's really the fact that the secured debt outstanding, the term loan B outstanding, is fairly close to the loan portfolio size.

Chris Mueller Analyst — Citizens

That makes sense. And then looking at the strategic review expenses, I guess I heard you guys mentioned the legal counsel and financial advisor. Is that all that's going into that bucket there? And is that an ongoing expense, or is it more one-time in nature?

Hi, Chris. It's Kendra. Thanks for the question. So I would say that the strategic review costs predominantly include financial advisors and legal advisors. I would point out that it is ongoing, as you asked, and also consider that the timing of when the Strategic Review Committee was formed. So the expenses were back-ended in Q3. So I think you can assume from that that in Q4, those expenses will grow on a full quarter basis. Helpful.

Chris Mueller Analyst — Citizens

I appreciate you guys taking the questions today. Thank you.

Operator

Your next question comes from Gabe Poggi with Raymond James. Your line is open.

Gabe Poggi Analyst — Raymond James

Hey, good morning. Thanks for taking the question. Matt, Patrick, I've got kind of a top of the house question. What is KKR doing holistically? I mean, Matt, you alluded to all the different buckets of capital that the team works on, right? What's KKR looking at across commercial real estate in this environment? What activity do they find is interesting? I noticed the life science JV with Alexandria that was publicly announced a few days ago. But any color you can provide as to kind of the opportunity to KKR or that you're seeing and doing in other pockets of capital away from the REIT, I think would be helpful. Thank you.

Thank you for the question, Gabe.

I guess you could break it down between equity and debt, and I'd say on the debt side, we remain active with all of our pools of capital and think it's an attractive lending environment for all the reasons we talk about on this call and for our peers' talk about ability to lend on a reset basis with supply coming down in a higher interest rate environment. I think it's a good credit story. We're seeing that demand from our insurance company, but also on the private debt fund side, I think there's a lot of capital getting allocated to the sector, and I'd say there we're continuing to invest in what you would expect in terms of on-theme assets from a property type, so nothing too new there. You saw in this quarter, we did a regional loan within KRF on senior housing. That's an area where we certainly have a lot of experience and positive experience on the equity side of our business and have been involved on the debt side. But in terms of new things we're looking at, that's probably one area that we're slightly more active. Otherwise, it continues to be heavily focused on multifamily and industrial lending for the most part. I think when you put the equity hat on, the market's probably opening up a little bit for us in terms of investing kind of the value-add opportunistic funds, and it's early days, but I think there's going to be a lot of investors, ourselves included, spending time in the multifamily segment of the market. I think Jade was pointing out the fact that supply is coming down, and yet now you have another pressure point on value, and this could be an interesting entry point, not to call the bottom, but certainly as you think about investing capital, it looks like an attractive place to go, and a lot of capital structures are coming due, like we talked about in our portfolio and in our peers. So, I think that's an area in particular we'll, you know, we'll spend more time on.

Gabe Poggi Analyst — Raymond James

Thank you.

Operator

This concludes our question and answer session. I would like to turn the conference back over to Jack Switala for any closing remarks.

Jack Switala Head of Investor Relations

Thanks, Operator, and thanks, everyone, for joining today. Please reach out to me or the team here if you have any questions. Take care.

Operator

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.

Analyst Q&A · 5 questions
Full-screen source Call document